SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?


To: rllee who wrote (52842)11/26/2013 11:49:07 AM
From: E_K_S  Read Replies (2) | Respond to of 78667
 
Liberator Medical Holdings, Inc. (LBMH) - Sold 50% of my shares as this stocked reached my "value" target price.

I still hold 50% of my shares in the IRA account but decided to cash in the shares in my taxable account as this one exceeded my target price of $3.40/share. I arrived at this price by estimating next years earnings (based on 20% growth) and factoring a 20 PE. The stock could very well exceed this if/when they continue on their sales growth path for several more quarters.

I like this company as it is a pure play on the medical sector w/ guaranteed payments by Medicare which allows them to post solid 33% margins. At some point, Medicare will want them to lower prices and/or margins which will impact future earnings.

EKS



To: rllee who wrote (52842)11/20/2015 8:49:16 AM
From: E_K_S  Respond to of 78667
 
Liberator Medical Holdings, Inc. (LBMH) - Liberator Medical Hlds to be acquired by C. R. Bard (BCR) for ~$181 Million, or $3.35/share

CR Bard Inc. (BCR) a big fish in the industry w/ a 14.4Bln market cap. Will take my $3.35/share (buys at $2.89/share 8/2014 and @ $2.35/share 8/2015).

The value bet pays off but BCR got a good deal. Stock worth North of $6.00/share.

EKS